TY - JOUR
T1 - Photobiomodulation alleviates Burning Mouth Syndrome pain
T2 - Immediate and weekly outcomes explored
AU - Finfter, Ori
AU - Kizel, Layla
AU - Czerninski, Rakefet
AU - Heiliczer, Shimrit
AU - Sharav, Yair
AU - Cohen, Rafael
AU - Aframian, Doron J.
AU - Haviv, Yaron
N1 - Publisher Copyright:
© 2024 Wiley Periodicals LLC.
PY - 2024/10
Y1 - 2024/10
N2 - Burning Mouth Syndrome (BMS) is an intraoral chronic burning or dysesthetic sensation, without clinically evident causative lesions on clinical examination and investigation. Aim: To assess immediate and weekly effects of photobiomodulation (PBM) on BMS patients. Methods: Thirty BMS patients were treated intra-orally with photobiomodulation 940(±10) nm (InGaAsP) 3 W, semi-conductor diode, weekly, for up to 10 weeks. Pain intensity, measured using the Visual Analogue Scale (VAS), and characteristics were recorded immidiately after each treatment, along with a weekly average VAS. Results: Immediate mean VAS score decreased from a starting score of 7.80 ± 1.83 to 2.07 ± 2.55 (p < 0.001). The mean weekly VAS score for the week after the final treatment session was higher (5.73 ± 2.80, p < 0.001) than the immediate response, but still significantly lower than the starting score (p = 0.017). We observed a trend of pain improvement with more treatments, but this was only statistically significant up to the third treatment. Male gender and unilateral pain correlated with better PBM efficacy (p = 0.017, 0.022, respectively). Conclusion: PBM provides significant immediate pain relief for BMS patients after each treatment; however, the efficacy decreases notably over the following week. A trend of increasing pain relief across treatments was observed, statistically significant up to the third treatment.
AB - Burning Mouth Syndrome (BMS) is an intraoral chronic burning or dysesthetic sensation, without clinically evident causative lesions on clinical examination and investigation. Aim: To assess immediate and weekly effects of photobiomodulation (PBM) on BMS patients. Methods: Thirty BMS patients were treated intra-orally with photobiomodulation 940(±10) nm (InGaAsP) 3 W, semi-conductor diode, weekly, for up to 10 weeks. Pain intensity, measured using the Visual Analogue Scale (VAS), and characteristics were recorded immidiately after each treatment, along with a weekly average VAS. Results: Immediate mean VAS score decreased from a starting score of 7.80 ± 1.83 to 2.07 ± 2.55 (p < 0.001). The mean weekly VAS score for the week after the final treatment session was higher (5.73 ± 2.80, p < 0.001) than the immediate response, but still significantly lower than the starting score (p = 0.017). We observed a trend of pain improvement with more treatments, but this was only statistically significant up to the third treatment. Male gender and unilateral pain correlated with better PBM efficacy (p = 0.017, 0.022, respectively). Conclusion: PBM provides significant immediate pain relief for BMS patients after each treatment; however, the efficacy decreases notably over the following week. A trend of increasing pain relief across treatments was observed, statistically significant up to the third treatment.
KW - BMS
KW - long-term laser therapy
KW - photobiomodulation
KW - short-term laser therapy
UR - http://www.scopus.com/inward/record.url?scp=85186428572&partnerID=8YFLogxK
U2 - 10.1111/odi.14900
DO - 10.1111/odi.14900
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38396381
AN - SCOPUS:85186428572
SN - 1354-523X
VL - 30
SP - 4668
EP - 4676
JO - Oral Diseases
JF - Oral Diseases
IS - 7
ER -